Trials / Completed
CompletedNCT04461756
Safety and Pharmacokinetics of Vaped Cannabis in Healthy Volunteers
A Phase I Exploratory Study to Assess the Pharmacokinetics of Single Inhaled Dose of Cannabis (Delta-9-Tetrahydrocannabinol / Cannabidiol) Administered by Vaporization Using a 4-Day Dose Titration In Healthy Male And Female Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Tetra Bio-Pharma · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The primary objective of this study was to evaluate the pharmacokinetics (PK) of THC, 11-OH-THC and CBD following a single inhaled dose of PPP001 administered by vaporization. The secondary objective of this study was to determine the safety and tolerability of THC and CBD after a single inhaled dose of PPP001 administered by vaporization in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PPP001 | inhalation (vape) |
Timeline
- Start date
- 2018-11-01
- Primary completion
- 2018-11-24
- Completion
- 2018-11-24
- First posted
- 2020-07-08
- Last updated
- 2020-07-10
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT04461756. Inclusion in this directory is not an endorsement.